Share

Q&A: Mary Korytkowski, MD, and Ranganath Muniyappa, MD, PhD

ENDO_2022_4C Ahead of their ENDO 2022 session on Monday June 13 from 11:00 a.m. to 12:30 p.m., Endocrine News talks with Mary Korytkowski, MD, and Ranganath Muniyappa, MD, PhD, chairs of the guideline development panel that created the latest Endocrine Society Clinical Practice Guideline on treating adult patients with hyperglycemia in a hospital setting. This month,...
Share

ENDO 2022: Day by Day

may 2022 cover No doubt your days will be packed while you’re at Atlanta’s Georgia World Congress Center, weaving through the crowds as you make your way to various sessions and presentations at ENDO 2022. Here are just a few highlights – among hundreds – that might appeal to you. Saturday June 11 Plenary: Envisioning Future Therapies for...
Share

ENDO 2022: GEORGIA, ON MY MIND

april 2022 cover As the Endocrine Society prepares to welcome the endocrinology community from around the world to Atlanta for ENDO 2022, Endocrine News is highlighting some of our host city’s local flair as well as a few components of the conference itself. Since this year’s annual meeting can be attended either in person or virtually, we look...
Share

Low Risk Thyroid Cancer: Rating the Risks

ENDO_2022_4C While certain thyroid cancer patients who have very small nodules well-located within the thyroid can be counseled rather than operated on, other patients might fare better undergoing surgery. At ENDO 2022, experts weigh in and debate when to operate and when to watch in patients with low-risk thyroid cancer in the session “Endocrine Debate: Low...
Share

All About Adrenal: Analyzing Two Years of Research

ENDO_2022_4C When the ENDO 2022 session “Clinical Year in Review: All Things Adrenal” gets underway, Gary Hammer, MD, PhD, will treat attendees to the series of advances that have been made in adrenal science and clinical practice over the last two years, from adrenal homeostasis, glucocorticoid biology, and adrenal insufficiency to Cushing’s, tumors, pheochromocytoma, and more....
Share

Gender-Affirming Care: Bridging the Gap

ENDO_2022_4C As transgender medical care becomes unfairly politicized, presentations such as ENDO 2022’s Meet the Professor session “Beginner’s Guide to Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Adults” are more essential than ever. Attendees will be shown a variety of best practices in providing affirming care to transgender and gender diverse adults.   On the...
Share

Does Thyroid Hormone Replacement Undertreatment Worsen Hospital Outcomes?

Study finds undertreatment can lead to longer stay and higher readmission rates. Undertreatment with thyroid hormone replacement can put patients with hypothyroidism at risk for worse hospital outcomes, including longer length of stay and higher rates of readmission, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism. Hypothyroidism, or...